For example, a client hit a 3-month stall post-GLP-1
This is why Tirzepatide (Mounjaro/Zepbound), which combines GLP-1 and GIP, produces better results than Semaglutide alone while causing less nausea (25% versus 44%)
doi: 10.2337/db14-0302 56 ChangCCLinTCHoHLKuoCYLiHHKorolenkoTAet al
In addition, data on suicide risk in patients on incretin therapies may be confounded by underlying conditions, including obesity and diabetes, which have been linked to increased suicide risk
A tailored program helps ensure stable blood sugar levels, balanced nutrition, and sustainable energy throughout the day
Your skin acts as a protective barrier, and even if small amounts of these compounds did get absorbed, research doesnt support that they would have any appetite-suppressing effects